TY  - JOUR

T1  - Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach

JO  - Molecular Pharmaceutics

UR  - http://dx.doi.org/10.1021/acs.molpharmaceut.2c00032

PY  - 2022/05/23

AU  - Ly HH

AU  - Daniel S

AU  - Soriano SKV

AU  - Kis Z

AU  - Blakney AK

ED  - 

DO  - DOI: 10.1021/acs.molpharmaceut.2c00032

PB  - American Chemical Society (ACS)

VL  - 19

IS  - 6

SP  - 1892

EP  - 1905

Y2  - 2024/12/29

ER  -